Skip to main content
Caplight Logo









Infinity Bio, Inc.

Infinity Bio, Inc.

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.infinitybio.com/

Last Round

Series A

Jun 18, 2025

Est. Valuation

$32M

Total Funding Raised

$12.5M

Company Overview

Infinity Bio, Inc. is a biotechnology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antibody profilingimmune profilingbiomarker discoveryMIPSAmolecular indexingautoimmunity profilingantibody reactomehigh-throughput sequencingtranslational medicineimmunology researchimmune mappingepitope mappingbiotech servicesproteomicsimmune repertoire

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Infinity Bio, Inc. Comparables

Compare Infinity Bio, Inc. with similar companies based on industry and business-model similarity.

Infinity Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CDI Labs
83%
Thermo Fisher Scientific Inc.
72%
Creative Biolabs
69%

Infinity Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 18, 2025
Early FundingOct 8, 2024

Key People

Founding team and executive leadership

Joy M. Nassif

Chief Executive Officer

Executive Team

Kelvin Liu

Chief Product Officer

Executive Team

Infinity Bio, Inc. Investors

Notable investors and investment history

Infinity Bio, Inc. investors
InvestorRounds
PTX CapitalSeries A, Early Funding
TCP Venture CapitalSeries A
TEDCOSeries A
Illumina VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 87% MoM.

  • Jun 18, 2025

    $8M round completed.

Infinity Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Infinity Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Infinity Bio, Inc.'s valuation, stock price, and market status.

Is Infinity Bio, Inc. a public or private company?

Infinity Bio, Inc. is a private company.

What is the current stock price of Infinity Bio, Inc.?

Infinity Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Infinity Bio, Inc. worth (valuation)?

Valuation information for Infinity Bio, Inc. is not publicly available.

Can I buy Infinity Bio, Inc. stock?

Infinity Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Infinity Bio, Inc.'s last funding round?

Infinity Bio, Inc.'s most recent funding round was Series A on June 18, 2025.

Who are the main investors in Infinity Bio, Inc.?

Key investors in Infinity Bio, Inc. include Illumina Ventures.

Will Infinity Bio, Inc. IPO soon?

No public IPO plans have been announced for Infinity Bio, Inc..

How can I track Infinity Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Infinity Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range17
Year Founded2023
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?